NF-kappa	B-protein
B	I-protein
as	O
inducible	O
transcriptional	B-protein
activator	I-protein
of	O
the	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
gene	I-DNA
.	O

The	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
is	O
induced	O
upon	O
activation	O
of	O
T	B-cell_type
cells	I-cell_type
with	O
phytohemagglutinin	B-protein
and	O
active	O
phorbolester	O
and	O
upon	O
expression	O
of	O
tax1	B-protein
,	O
a	O
transactivating	B-protein
protein	I-protein
of	O
the	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
.	O

The	O
same	O
agents	O
induce	O
transcription	O
from	O
the	O
interleukin-2	B-DNA
receptor	I-DNA
alpha-chain	I-DNA
and	I-DNA
interleukin-2	I-DNA
genes	I-DNA
,	O
depending	O
on	O
promoter	B-DNA
elements	I-DNA
that	O
bind	O
the	O
inducible	B-protein
transcription	I-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
(	O
or	O
an	O
NF-kappa	B-protein
B-like	I-protein
factor	I-protein
)	O
.	O

We	O
therefore	O
tested	O
the	O
possibility	O
that	O
the	O
GM-CSF	B-DNA
gene	I-DNA
is	O
also	O
regulated	O
by	O
a	O
cognate	O
motif	O
for	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
.	O

A	O
recent	O
functional	O
analysis	O
by	O
Miyatake	O
et	O
al.	O
(	O
S.	O
Miyatake	O
,	O
M.	O
Seiki	O
,	O
M.	O
Yoshida	O
,	O
and	O
K.	O
Arai	O
,	O
Mol.	O
Cell.	O
Biol.	O
8	O
:	O
5581-5587	O
,	O
1988	O
)	O
described	O
a	O
short	B-DNA
promoter	I-DNA
region	I-DNA
in	O
the	O
GM-CSF	B-DNA
gene	I-DNA
that	O
conferred	O
strong	O
inducibility	O
by	O
T-cell-activating	O
signals	O
and	O
tax1	B-protein
,	O
but	O
no	O
NF-kappa	B-DNA
B-binding	I-DNA
motifs	I-DNA
were	O
identified	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
showed	O
binding	O
of	O
purified	O
human	B-protein
NF-kappa	I-protein
B	I-protein
and	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
activated	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
to	O
an	O
oligonucleotide	O
comprising	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
element	I-DNA
responsible	O
for	O
mediating	O
responsiveness	O
to	O
T-cell-activating	O
signals	O
and	O
tax1	B-protein
.	O

As	O
shown	O
by	O
a	O
methylation	O
interference	O
analysis	O
and	O
oligonucleotide	O
competition	O
experiments	O
,	O
purified	O
NF-kappa	B-protein
B	I-protein
binds	O
at	O
positions	B-DNA
-82	I-DNA
to	I-DNA
-91	I-DNA
(	O
GGGAACTACC	O
)	O
of	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
sequence	O
with	O
an	O
affinity	O
similar	O
to	O
that	O
with	O
which	O
it	O
binds	O
to	O
the	O
biologically	B-DNA
functional	I-DNA
kappa	I-DNA
B	I-DNA
motif	I-DNA
in	O
the	O
beta	B-DNA
interferon	I-DNA
promoter	I-DNA
(	O
GGGAAATTCC	O
)	O
.	O

Two	O
kappa	B-DNA
B-like	I-DNA
motifs	I-DNA
at	O
positions	B-DNA
-98	I-DNA
to	I-DNA
-108	I-DNA
of	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
were	O
also	O
recognized	O
but	O
with	O
much	O
lower	O
affinities	O
.	O

Our	O
data	O
provide	O
strong	O
evidence	O
that	O
the	O
expression	O
of	O
the	O
GM-CSF	B-DNA
gene	I-DNA
following	O
T-cell	O
activation	O
is	O
controlled	O
by	O
binding	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
to	O
a	O
high-affinity	B-DNA
binding	I-DNA
site	I-DNA
in	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
.	O

MoLEcULar	NULL
aAnp	NULL
CELLULAR	NULL
BroLOoGYy	NULL
,	NULL
Mar	NULL
.	NULL

1990	NULL
,	NULL
p.	NULL
1281-1286	NULL
0270-7306/90/031281-06	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1990	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

10	NULL
,	NULL
No	NULL
.	NULL

3	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
Inducible	NULL
Transcriptional	NULL
Activator	NULL
of	NULL
the	NULL
Granulocyte	NULL
Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
Gene	NULL
RALF	NULL
SCHRECK	NULL
ano	NULL
PATRICK	NULL
A.	NULL
BAEUERLE*	NULL
Laboratorium	NULL
fiir	NULL
molekulare	NULL
Biologie	NULL
der	NULL
Ludwig-Maximilians-Universitit	NULL
Miinchen	NULL
,	NULL
Genzentrum	NULL
,	NULL
Am	NULL
Klopferspitz	NULL
,	NULL
D-8033	NULL
Martinsried	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
Received	NULL
5	NULL
October	NULL
1989/Accepted	NULL
5	NULL
December	NULL
1989	NULL
The	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
is	NULL
induced	NULL
upon	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
phytohemagglutinin	NULL
and	NULL
active	NULL
phorbolester	NULL
and	NULL
upon	NULL
expression	NULL
of	NULL
tax	NULL
,	NULL
,	NULL
a	NULL
transactivating	NULL
protein	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
.	NULL

The	NULL
same	NULL
agents	NULL
induce	NULL
transcription	NULL
from	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
and	NULL
interleukin-2	NULL
genes	NULL
,	NULL
depending	NULL
on	NULL
promoter	NULL
elements	NULL
that	NULL
bind	NULL
the	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-B	NULL
(	NULL
or	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
GM-CSF	NULL
gene	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
a	NULL
cognate	NULL
motif	NULL
for	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
.	NULL

A	NULL
recent	NULL
functional	NULL
analysis	NULL
by	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
S.	NULL
Miyatake	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
,	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:5581-5587	NULL
,	NULL
1988	NULL
)	NULL
described	NULL
a	NULL
short	NULL
promoter	NULL
region	NULL
in	NULL
the	NULL
GM-CSF	NULL
gene	NULL
that	NULL
conferred	NULL
strong	NULL
inducibility	NULL
by	NULL
T-cell-activating	NULL
signals	NULL
and	NULL
tax	NULL
,	NULL
,	NULL
but	NULL
no	NULL
NF-	NULL
«	NULL
B-binding	NULL
motifs	NULL
were	NULL
identified	NULL
.	NULL

Using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
we	NULL
showed	NULL
binding	NULL
of	NULL
purified	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
to	NULL
an	NULL
oligonucleotide	NULL
comprising	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
element	NULL
responsible	NULL
for	NULL
mediating	NULL
responsiveness	NULL
to	NULL
T-cell-activating	NULL
signals	NULL
and	NULL
tax	NULL
,	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
a	NULL
methylation	NULL
interference	NULL
analysis	NULL
and	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
,	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
binds	NULL
at	NULL
positions	NULL
-82	NULL
to	NULL
-91	NULL
(	NULL
GGGAACTACC	NULL
)	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
sequence	NULL
with	NULL
an	NULL
affinity	NULL
similar	NULL
to	NULL
that	NULL
with	NULL
which	NULL
it	NULL
binds	NULL
to	NULL
the	NULL
biologically	NULL
functional	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
(	NULL
GGGAAATTCC	NULL
)	NULL
.	NULL

Two	NULL
B-like	NULL
motifs	NULL
at	NULL
positions	NULL
-98	NULL
to	NULL
-108	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
were	NULL
also	NULL
recognized	NULL
but	NULL
with	NULL
much	NULL
lower	NULL
affinities	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
strong	NULL
evidence	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
following	NULL
T-cell	NULL
activation	NULL
is	NULL
controlled	NULL
by	NULL
binding	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
to	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

The	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
viruses	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
16	NULL
)	NULL
.	NULL

A	NULL
characteristic	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
that	NULL
it	NULL
exists	NULL
in	NULL
a	NULL
latent	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
cells	NULL
and	NULL
thus	NULL
not	NULL
only	NULL
is	NULL
rapidly	NULL
activated	NULL
upon	NULL
stimulation	NULL
of	NULL
cells	NULL
without	NULL
de	NULL
novo	NULL
synthesis	NULL
but	NULL
also	NULL
can	NULL
participate	NULL
in	NULL
signaling	NULL
between	NULL
the	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
inactive	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
apparently	NULL
stabilized	NULL
by	NULL
a	NULL
specific	NULL
inhibitory	NULL
protein	NULL
designated	NULL
IxB	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Deoxycholate	NULL
(	NULL
DOC	NULL
)	NULL
can	NULL
dissociate	NULL
the	NULL
inactive	NULL
complex	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
IB	NULL
in	NULL
vitro	NULL
,	NULL
thereby	NULL
activating	NULL
NF-kB	NULL
.	NULL

In	NULL
intact	NULL
cells	NULL
,	NULL
a	NULL
large	NULL
number	NULL
of	NULL
agents	NULL
were	NULL
found	NULL
to	NULL
activate	NULL
NF-kB	NULL
,	NULL
among	NULL
them	NULL
12-O-tetrade-canoylphorbol	NULL
1l3-acetate	NULL
(	NULL
TPA	NULL
)	NULL
,	NULL
lipopolysaccharide	NULL
,	NULL
lec-tins	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
cyclic	NULL
AMP	NULL
,	NULL
the	NULL
tax	NULL
,	NULL
;	NULL
protein	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
,	NULL
and	NULL
the	NULL
X	NULL
protein	NULL
of	NULL
hepatitis	NULL
virus	NULL
type	NULL
B	NULL
(	NULL
16	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
how	NULL
the	NULL
distinct	NULL
intracellular	NULL
signals	NULL
elicited	NULL
by	NULL
these	NULL
agents	NULL
funnel	NULL
into	NULL
the	NULL
NF-	NULL
«	NULL
kB-IxB	NULL
complex	NULL
,	NULL
resulting	NULL
in	NULL
its	NULL
dissociation	NULL
.	NULL

NF-kB	NULL
,	NULL
a	NULL
widely	NULL
used	NULL
mediator	NULL
of	NULL
immediate-early	NULL
gene	NULL
expression	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
is	NULL
apparently	NULL
also	NULL
used	NULL
in	NULL
T	NULL
lymphocytes	NULL
to	NULL
rapidly	NULL
activate	NULL
genes	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

Three	NULL
well-studied	NULL
examples	NULL
are	NULL
the	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
)	NULL
gene	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
17	NULL
)	NULL
,	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
12	NULL
,	NULL
22	NULL
)	NULL
.	NULL

In	NULL
all	NULL
three	NULL
systems	NULL
,	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
confer	NULL
inducibility	NULL
to	NULL
the	NULL
promoters	NULL
by	NULL
T-cell-activating	NULL
signals	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
tax	NULL
,	NULL
protein	NULL
from	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
has	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

1281	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
genes	NULL
via	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
4	NULL
,	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
kB	NULL
sites	NULL
that	NULL
prevent	NULL
factor	NULL
binding	NULL
abolished	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
a	NULL
TPA-phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
or	NULL
a	NULL
TPA-calcium	NULL
ionophore	NULL
treatment	NULL
mimicking	NULL
T-cell	NULL
activation	NULL
and	NULL
upon	NULL
transient	NULL
expression	NULL
of	NULL
tax	NULL
,	NULL
(	NULL
7	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
a	NULL
deletion	NULL
and	NULL
mutation	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
region	NULL
,	NULL
two	NULL
short	NULL
sequence	NULL
elements	NULL
between	NULL
positions	NULL
-113	NULL
and	NULL
-73	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
that	NULL
were	NULL
sufficient	NULL
to	NULL
confer	NULL
inducibility	NULL
to	NULL
the	NULL
chloramphenicol	NULL
trans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
were	NULL
identified	NULL
(	NULL
20	NULL
)	NULL
.	NULL

An	NULL
element	NULL
between	NULL
positions	NULL
-95	NULL
and	NULL
-73	NULL
conferred	NULL
a	NULL
strong	NULL
response	NULL
to	NULL
T-cell-activating	NULL
signals	NULL
as	NULL
well	NULL
as	NULL
to	NULL
transient	NULL
expression	NULL
of	NULL
tax	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

A	NULL
second	NULL
element	NULL
responding	NULL
only	NULL
weakly	NULL
to	NULL
transient	NULL
tax	NULL
,	NULL
expression	NULL
but	NULL
not	NULL
to	NULL
T-cell-activating	NULL
signals	NULL
was	NULL
located	NULL
between	NULL
positions	NULL
-113	NULL
and	NULL
-95	NULL
.	NULL

Although	NULL
no	NULL
protein-binding	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
this	NULL
study	NULL
,	NULL
the	NULL
cis-acting	NULL
effects	NULL
were	NULL
attributed	NULL
to	NULL
conserved	NULL
lymphokine	NULL
elements	NULL
designated	NULL
CLE	NULL
1	NULL
and	NULL
CLE	NULL
2	NULL
and	NULL
a	NULL
GC	NULL
box	NULL
present	NULL
within	NULL
the	NULL
segment	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Because	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
were	NULL
shown	NULL
to	NULL
confer	NULL
transcriptional	NULL
responses	NULL
,	NULL
as	NULL
those	NULL
found	NULL
with	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
elements	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
GM-CSF	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
this	NULL
transcription	NULL
ractor	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cis-acting	NULL
element	NULL
conferring	NULL
strong	NULL
inducibility	NULL
upon	NULL
T-cell	NULL
activation	NULL
and	NULL
tax	NULL
,	NULL
.	NULL

The	NULL
CLE	NULL
1	NULL
motif	NULL
which	NULL
confers	NULL
only	NULL
weak	NULL
inducibility	NULL
by	NULL
tax	NULL
;	NULL
is	NULL
a	NULL
low-affinity	NULL
binding	NULL
site	NULL
for	NULL
NF-kB	NULL
.	NULL

Combined	NULL
with	NULL
the	NULL
data	NULL
from	NULL
the	NULL
deletion	NULL
and	NULL
mutation	NULL
analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
20	NULL
,	NULL
23	NULL
)	NULL
,	NULL
our	NULL
data	NULL
strongly	NULL
1282	NULL
NOTES	NULL
A	NULL
GM-CSF	NULL
Gene	NULL
113	NULL
CLE1	NULL
CLE	NULL
2	NULL
GC	NULL
-70	NULL
-	NULL
Mmmkmlrcmuh	NULL
’	NULL
gwocmcc	NULL
free	NULL
--	NULL
-	NULL
p40	NULL
tax	NULL
and	NULL
T	NULL
Cel	NULL
Activation	NULL
Signals	NULL
B	NULL
Oligonucieotides	NULL
413	NULL
-70	NULL
GM-CSF1	NULL
L	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
casera	NULL
att	NULL
--	NULL
-L______	NULL
xB	NULL
|	NULL
o	NULL
am-csFr2	NULL
GBCca	NULL
GGAGATTCCA	NULL
CAAC	NULL
T	NULL
B	NULL
'	NULL
C	NULL
Ig	NULL
«	NULL
enhancer	NULL
(	NULL
mouse	NULL
)	NULL
GooactTTcc	NULL
SV	NULL
40	NULL
,	NULL
HIV	NULL
,	NULL
SAA	NULL
IL-2R	NULL
(	NULL
human	NULL
)	NULL
GGGaaTCTCC	NULL
B-IFN	NULL
(	NULL
human	NULL
)	NULL
GGGaAaAATTCC	NULL
IL-2	NULL
(	NULL
human	NULL
)	NULL
GGGaTTTCaAc	NULL
Consensus	NULL
GGGaANNYYCC	NULL
(	NULL
A	NULL
)	NULL
GM-CSF	NULL
(	NULL
-82/-91	NULL
)	NULL
GM-CSF	NULL
(	NULL
-99/-108	NULL
)	NULL
TIGGAATCTCC	NULL
GM-CSF	NULL
(	NULL
-107/-98	NULL
)	NULL
GAcaTTCCAC	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
upstream	NULL
promoter	NULL
as	NULL
described	NULL
by	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
motifs	NULL
CLE	NULL
1	NULL
,	NULL
CLE	NULL
2	NULL
,	NULL
and	NULL
the	NULL
GC	NULL
box	NULL
and	NULL
their	NULL
proposed	NULL
functional	NULL
significance	NULL
in	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
sequences	NULL
that	NULL
are	NULL
shown	NULL
in	NULL
alignment	NULL
with	NULL
that	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
the	NULL
double-stranded	NULL
oligonucleotides	NULL
contained	NULL
HindIII	NULL
and	NULL
Sall	NULL
linker	NULL
sequences	NULL
on	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
putative	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
(	NULL
xB	NULL
and	NULL
<	NULL
B	NULL
'	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
brackets	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Alignment	NULL
of	NULL
the	NULL
«	NULL
B	NULL
motifs	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
with	NULL
physiological	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

kB	NULL
motifs	NULL
that	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
functional	NULL
significance	NULL
for	NULL
inducible	NULL
gene	NULL
expression	NULL
(	NULL
16	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
are	NULL
aligned	NULL
,	NULL
and	NULL
a	NULL
consensus	NULL
sequence	NULL
is	NULL
shown	NULL
(	NULL
N	NULL
,	NULL
any	NULL
nucleotide	NULL
;	NULL
Y	NULL
,	NULL
pyrimidines	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
strand	NULL
that	NULL
contains	NULL
the	NULL
three	NULL
clustered	NULL
conserved	NULL
guanosine	NULL
residues	NULL
whose	NULL
methylation	NULL
interferes	NULL
with	NULL
factor	NULL
binding	NULL
is	NULL
depicted	NULL
.	NULL

Three	NULL
kB-like	NULL
elements	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
are	NULL
shown	NULL
,	NULL
and	NULL
their	NULL
positions	NULL
in	NULL
the	NULL
promoter	NULL
are	NULL
indicated	NULL
with	NULL
reference	NULL
to	NULL
the	NULL
sequence	NULL
in	NULL
panel	NULL
A.	NULL
T	NULL
,	NULL
Deviation	NULL
from	NULL
the	NULL
human	NULL
IL2-R	NULL
site	NULL
;	NULL
A	NULL
and	NULL
C	NULL
,	NULL
deviations	NULL
from	NULL
the	NULL
human	NULL
IL-2	NULL
site	NULL
;	NULL
Ig	NULL
,	NULL
immunoglobulin	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
;	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
B-IFN	NULL
,	NULL
beta	NULL
interferon	NULL
;	NULL
SAA	NULL
,	NULL
serum	NULL
amyloid	NULL
A.	NULL
suggest	NULL
that	NULL
NF-kB	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

Putative	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
upstream	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

We	NULL
identified	NULL
by	NULL
inspection	NULL
three	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
within	NULL
promoter	NULL
elements	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
that	NULL
were	NULL
shown	NULL
earlier	NULL
to	NULL
confer	NULL
inducible	NULL
expression	NULL
by	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
tax	NULL
,	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

when	NULL
inserted	NULL
into	NULL
constructs	NULL
containing	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
(	NULL
20	NULL
)	NULL
.	NULL

One	NULL
potential	NULL
NF-xB-binding	NULL
site	NULL
is	NULL
located	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
overlapping	NULL
the	NULL
sequence	NULL
elements	NULL
designated	NULL
CLE	NULL
2	NULL
and	NULL
GC	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
site	NULL
has	NULL
the	NULL
sequence	NULL
GGGAACTACC	NULL
and	NULL
differs	NULL
only	NULL
by	NULL
a	NULL
purine	NULL
in	NULL
position	NULL
8	NULL
from	NULL
the	NULL
consensus	NULL
sequence	NULL
GGGANNYYCC	NULL
that	NULL
was	NULL
delineated	NULL
by	NULL
comparing	NULL
biologically	NULL
functional	NULL
NF-sites	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
KB-like	NULL
sequences	NULL
are	NULL
present	NULL
in	NULL
the	NULL
sequence	NULL
element	NULL
designated	NULL
CLE	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
C	NULL
)	NULL
,	NULL
which	NULL
is	NULL
conserved	NULL
among	NULL
promoters	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
(	NULL
for	NULL
a	NULL
list	NULL
of	NULL
such	NULL
genes	NULL
,	NULL
see	NULL
reference	NULL
26	NULL
)	NULL
.	NULL

A	NULL
putative	NULL
site	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
has	NULL
the	NULL
sequence	NULL
GAGAT	NULL
TCCAC	NULL
and	NULL
differs	NULL
by	NULL
an	NULL
A	NULL
in	NULL
position	NULL
2	NULL
and	NULL
by	NULL
a	NULL
C	NULL
in	NULL
position	NULL
7	NULL
from	NULL
the	NULL
functional	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Another	NULL
site	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
has	NULL
the	NULL
sequence	NULL
TGGAATCTCC	NULL
and	NULL
deviates	NULL
from	NULL
the	NULL
functional	NULL
site	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
-chain	NULL
(	NULL
5	NULL
)	NULL
gene	NULL
only	NULL
in	NULL
position	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

High-affinity	NULL
binding	NULL
of	NULL
purified	NULL
to	NULL
a	NULL
site	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
NF-kB	NULL
would	NULL
bind	NULL
to	NULL
the	NULL
putative	NULL
sites	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
with	NULL
an	NULL
affinity	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
biologically	NULL
functional	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
analysis	NULL
comprising	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
and	NULL
oligonucleotide	NULL
competi-tions	NULL
.	NULL

Four	NULL
double-stranded	NULL
34-mer	NULL
oligonucleotides	NULL
containing	NULL
in	NULL
their	NULL
centers	NULL
the	NULL
NF-	NULL
«	NULL
kB-binding	NULL
sites	NULL
found	NULL
in	NULL
the	NULL
IL-2R	NULL
and	NULL
IL-2	NULL
promoters	NULL
and	NULL
the	NULL
putative	NULL
sites	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
labeled	NULL
with	NULL
{	NULL
«	NULL
-	NULL
>	NULL
P	NULL
]	NULL
JdCTP	NULL
by	NULL
the	NULL
Klenow	NULL
enzyme	NULL
to	NULL
the	NULL
same	NULL
specific	NULL
activity	NULL
and	NULL
reacted	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
NF-kB	NULL
purified	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
human	NULL
placenta	NULL
.	NULL

EMSAs	NULL
were	NULL
essentially	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

A	NULL
typical	NULL
binding	NULL
reaction	NULL
contained	NULL
1	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Phar-macia	NULL
)	NULL
,	NULL
5,000	NULL
to	NULL
10,000	NULL
cpm	NULL
(	NULL
Cerenkov	NULL
counting	NULL
)	NULL
of	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
,	NULL
2	NULL
pul	NULL
of	NULL
buffer	NULL
D	NULL
(	NULL
9	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
20	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
binding	NULL
buffer	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
xB	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
was	NULL
about	NULL
50	NULL
pg	NULL
per	NULL
assay	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
human	NULL
placenta	NULL
(	NULL
U.	NULL
Zabel	NULL
and	NULL
P.	NULL
Baeuerle	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
and	NULL
consisted	NULL
of	NULL
a	NULL
50-kilodalton	NULL
(	NULL
kDa	NULL
)	NULL
and	NULL
a	NULL
65-kDa	NULL
polypeptide	NULL
,	NULL
as	NULL
recently	NULL
described	NULL
for	NULL
the	NULL
NF-kB	NULL
from	NULL
cytosol	NULL
of	NULL
HeLa	NULL
cells	NULL
(	NULL
2a	NULL
)	NULL
and	NULL
as	NULL
observed	NULL
with	NULL
the	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
GM-CSFI1	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
was	NULL
as	NULL
strongly	NULL
complexed	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
were	NULL
the	NULL
IL-2R	NULL
and	NULL
IL-2	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
GM-CSF2	NULL
probe	NULL
was	NULL
bound	NULL
by	NULL
NF-kB	NULL
but	NULL
gave	NULL
rise	NULL
to	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
the	NULL
complex	NULL
obtained	NULL
with	NULL
the	NULL
other	NULL
probes	NULL
.	NULL

In	NULL
a	NULL
subsequent	NULL
experiment	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
purified	NULL
NF-kB	NULL
to	NULL
a	NULL
radiolabeled	NULL
probe	NULL
containing	NULL
the	NULL
frequently	NULL
found	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
GG	NULL
GACTTTCC	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
was	NULL
inhibited	NULL
by	NULL
2.5-	NULL
,	NULL
25-	NULL
,	NULL
and	NULL
250-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
.	NULL

This	NULL
allowed	NULL
us	NULL
to	NULL
estimate	NULL
the	NULL
relative	NULL
affinities	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
the	NULL
GM-CSF	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
comparison	NULL
to	NULL
well-characterized	NULL
functional	NULL
sites	NULL
.	NULL

The	NULL
unlabeled	NULL
oligonucleotide	NULL
kB	NULL
was	NULL
the	NULL
best	NULL
competitor	NULL
,	NULL
indicating	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
had	NULL
the	NULL
highest	NULL
affinity	NULL
for	NULL
this	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
GM-CSF1	NULL
oligonucleotide	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
kB	NULL
site	NULL
better	NULL
than	NULL
the	NULL
IL-2	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
somewhat	NULL
less	NULL
than	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
biologically	NULL
active	NULL
NF-	NULL
«	NULL
xB-binding	NULL
site	NULL
from	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
(	NULL
15	NULL
,	NULL
28	NULL
)	NULL
showed	NULL
a	NULL
profile	NULL
of	NULL
competition	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
GM-CSF1	NULL
oligonucleotide	NULL
,	NULL
indicating	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
had	NULL
a	NULL
similar	NULL
affinity	NULL
for	NULL
the	NULL
two	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

An	NULL
unrelated	NULL
oligonucleotide	NULL
caused	NULL
no	NULL
significant	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
NOTES	NULL
1283	NULL
A	NULL
B	NULL
kB	NULL
GM-CSF	NULL
1	NULL
GM-CSF	NULL
2	NULL
b	NULL
‘	NULL
(	NULL
N	NULL
100	NULL
£	NULL
Probe	NULL
:	NULL
-	NULL
*	NULL
~	NULL
«	NULL
&	NULL
/	NULL
robe	NULL
:	NULL
-	NULL
[	NULL
*	NULL
J	NULL
#	NULL
#	NULL
so	NULL
R	NULL
I	NULL
e	NULL
]	NULL
3	NULL
hh	NULL
8	NULL
o	NULL
wam	NULL
__	NULL
ew	NULL
4	NULL
0	NULL
-	NULL
2250	NULL
250	NULL
25s	NULL
0	NULL
0	NULL
250	NULL
£5	NULL
0	NULL
25	NULL
6	NULL
25	NULL
as	NULL
oss	NULL
it	NULL
ng	NULL
Oligo	NULL
--	NULL
B-IFN	NULL
IL-2	NULL
LJ	NULL
O	NULL
CC	NULL
L	NULL
o.	NULL
unt	NULL
100	NULL
%	NULL
>	NULL
l	NULL
so	NULL
I	NULL
I	NULL
|	NULL
I	NULL
2	NULL
l	NULL
fs	NULL
wes	NULL
0	NULL
.25	NULL
2.5	NULL
25	NULL
0	NULL
.25	NULL
25	NULL
2.5	NULL
(	NULL
.25	NULL
2.5	NULL
25	NULL
ng	NULL
Oligo	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Binding	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
sequences	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
comparison	NULL
to	NULL
various	NULL
other	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Direct	NULL
binding	NULL
analysis	NULL
by	NULL
EMSA	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
(	NULL
about	NULL
50	NULL
pg	NULL
)	NULL
purified	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
human	NULL
placenta	NULL
was	NULL
reacted	NULL
with	NULL
various	NULL
*P-labeled	NULL
oligonucleotides	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

They	NULL
were	NULL
extended	NULL
by	NULL
Sall	NULL
and	NULL
HindIII	NULL
linker	NULL
sites	NULL
to	NULL
26-mers	NULL
.	NULL

For	NULL
use	NULL
in	NULL
EMSAs	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
annealed	NULL
34-mers	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
with	NULL
the	NULL
Klenow	NULL
enzyme	NULL
(	NULL
Boehringer	NULL
GmbH	NULL
)	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

Symbols	NULL
:	NULL
»	NULL
,	NULL
position	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-DNA	NULL
complex	NULL
;	NULL
[	NULL
>	NULL
,	NULL
position	NULL
of	NULL
free	NULL
DNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Relative	NULL
affinities	NULL
of	NULL
the	NULL
NF-kB-binding	NULL
sites	NULL
.	NULL

For	NULL
binding	NULL
reactions	NULL
,	NULL
six	NULL
different	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
0.25	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
25	NULL
ng	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
0.1	NULL
ng	NULL
of	NULL
*P-end-labeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-kB-binding	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
«	NULL
light-chain	NULL
enhancer	NULL
(	NULL
«	NULL
B	NULL
)	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
nonspecific	NULL
oligonucleotide	NULL
(	NULL
unr	NULL
,	NULL
unrelated	NULL
,	NULL
;	NULL
40-mer	NULL
)	NULL
,	NULL
all	NULL
others	NULL
were	NULL
34-mers	NULL
and	NULL
annealed	NULL
from	NULL
26-mers	NULL
.	NULL

The	NULL
decameric	NULL
NF-xB-binding	NULL
site	NULL
was	NULL
located	NULL
in	NULL
the	NULL
center	NULL
and	NULL
flanked	NULL
by	NULL
four	NULL
to	NULL
six	NULL
nucleotides	NULL
from	NULL
the	NULL
original	NULL
cis-acting	NULL
elements	NULL
and	NULL
by	NULL
Sa/l	NULL
and	NULL
Hindlll	NULL
linker	NULL
sequences	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
binding	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB-DNA	NULL
complex	NULL
in	NULL
native	NULL
gels	NULL
(	NULL
determined	NULL
by	NULL
Cerenkov	NULL
counting	NULL
)	NULL
,	NULL
by	NULL
comparison	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
complex	NULL
obtained	NULL
from	NULL
binding	NULL
reactions	NULL
that	NULL
did	NULL
not	NULL
contain	NULL
cold	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

B-IFN	NULL
,	NULL
Beta	NULL
interferon	NULL
;	NULL
Oligo	NULL
,	NULL
oligonucieotide	NULL
.	NULL

competition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
within	NULL
the	NULL
concentration	NULL
range	NULL
tested	NULL
.	NULL

The	NULL
order	NULL
of	NULL
affinities	NULL
appeared	NULL
to	NULL
be	NULL
as	NULL
follows	NULL
:	NULL
kB	NULL
>	NULL
GM-CSF1	NULL
>	NULL
beta	NULL
interferon	NULL
>	NULL
IL-2	NULL
.	NULL

These	NULL
in	NULL
vitro	NULL
data	NULL
suggest	NULL
that	NULL
NF-kB	NULL
can	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
a	NULL
site	NULL
within	NULL
the	NULL
GM-CSF1	NULL
oligonucleotide	NULL
.	NULL

Because	NULL
this	NULL
oligonucleotide	NULL
corresponds	NULL
to	NULL
a	NULL
promoter	NULL
element	NULL
that	NULL
confers	NULL
inducible	NULL
gene	NULL
expression	NULL
upon	NULL
T-cell	NULL
activation	NULL
and	NULL
upon	NULL
tax	NULL
,	NULL
expression	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
NF-kB	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
transcription	NULL
factor	NULL
responsible	NULL
for	NULL
mediating	NULL
these	NULL
effects	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
the	NULL
binding	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
the	NULL
GM-CSF	NULL
?	NULL

oligonucleotide	NULL
containing	NULL
the	NULL
other	NULL
two	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
competed	NULL
only	NULL
weakly	NULL
with	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
kB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
compared	NULL
with	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
,	NULL
its	NULL
competition	NULL
was	NULL
significant	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Although	NULL
NF-kB	NULL
appears	NULL
to	NULL
bind	NULL
with	NULL
an	NULL
affinity	NULL
at	NULL
least	NULL
1	NULL
order	NULL
of	NULL
magnitude	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
site	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
GM-CSF2	NULL
oligonucleotide	NULL
,	NULL
its	NULL
binding	NULL
might	NULL
still	NULL
be	NULL
relevant	NULL
in	NULL
vivo	NULL
after	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
tax	NULL
,	NULL
and	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
weak	NULL
tax	NULL
,	NULL
responsiveness	NULL
localized	NULL
to	NULL
the	NULL
CLE	NULL
1	NULL
motif	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Novel	NULL
binding	NULL
motif	NULL
for	NULL
A	NULL
methylation	NULL
interference	NULL
analysis	NULL
allowed	NULL
us	NULL
to	NULL
determine	NULL
how	NULL
NF-	NULL
«	NULL
B	NULL
contacted	NULL
the	NULL
high-affinity	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

The	NULL
method	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

After	NULL
separation	NULL
of	NULL
DNA	NULL
complexed	NULL
by	NULL
purified	NULL
NF-kB	NULL
from	NULL
free	NULL
DNA	NULL
,	NULL
the	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
was	NULL
immersed	NULL
in	NULL
EMSA	NULL
running	NULL
buffer	NULL
(	NULL
25	NULL
)	NULL
containing	NULL
0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

In	NULL
the	NULL
same	NULL
buffer	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
onto	NULL
DEAE	NULL
paper	NULL
by	NULL
semidry	NULL
blotting	NULL
(	NULL
Sartorius	NULL
equipment	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
a	NULL
constant	NULL
current	NULL
of	NULL
0.5	NULL
A	NULL
.	NULL

After	NULL
1	NULL
h	NULL
of	NULL
autoradiography	NULL
,	NULL
the	NULL
portions	NULL
containing	NULL
the	NULL
DNA	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
filter	NULL
and	NULL
eluted	NULL
overnight	NULL
at	NULL
65°C	NULL
in	NULL
TE-1	NULL
M	NULL
NaCi-0.2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

The	NULL
eluates	NULL
were	NULL
centrifuged	NULL
and	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
before	NULL
cleavage	NULL
by	NULL
piperidine	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
methylation	NULL
of	NULL
six	NULL
purines	NULL
in	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
1284	NULL
NOTES	NULL
A	NULL
Strand	NULL
:	NULL
«	NULL
--	NULL
l	NULL
1	NULL
1	NULL
f	NULL
1	NULL
:	NULL
f	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
xB-GM-CSF	NULL
oligonucleotide	NULL
complex	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Fluorogram	NULL
of	NULL
a	NULL
12	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
4	NULL
,	NULL
purines	NULL
(	NULL
G+A	NULL
)	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
free	NULL
DNA	NULL
(	NULL
F	NULL
)	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
,	NULL
complexed	NULL
DNA	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Symbols	NULL
:	NULL
@	NULL
,	NULL
Purine	NULL
residues	NULL
that	NULL
interfere	NULL
with	NULL
binding	NULL
of	NULL
NF-kB	NULL
when	NULL
methyl-ated	NULL
;	NULL
<	NULL
,	NULL
purines	NULL
that	NULL
do	NULL
not	NULL
interfere	NULL
significantly	NULL
with	NULL
DNA	NULL
binding	NULL
of	NULL
NF-kB	NULL
when	NULL
methylated	NULL
.	NULL

For	NULL
the	NULL
analysis	NULL
,	NULL
an	NULL
oligonucleotide	NULL
that	NULL
contained	NULL
GM-CSF	NULL
sequences	NULL
from	NULL
-97	NULL
to	NULL
-70	NULL
was	NULL
used	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
coding	NULL
(	NULL
top	NULL
)	NULL
and	NULL
noncoding	NULL
(	NULL
bottom	NULL
)	NULL
strands	NULL
are	NULL
shown	NULL
.	NULL

Symbol	NULL
:	NULL
«	NULL
+++	NULL
,	NULL
purine	NULL
residues	NULL
essential	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
.	NULL

four	NULL
purines	NULL
in	NULL
the	NULL
coding	NULL
strand	NULL
interfered	NULL
strongly	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

A	NULL
10-base-pair	NULL
sequence	NULL
at	NULL
positions	NULL
-82	NULL
to	NULL
-91	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
could	NULL
be	NULL
defined	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
NF-kB	NULL
.	NULL

It	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
other	NULL
well-characterized	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
,	NULL
except	NULL
for	NULL
the	NULL
adenosine	NULL
in	NULL
position	NULL
8	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
«	NULL
kB-like	NULL
motifs	NULL
at	NULL
positions	NULL
-108	NULL
to	NULL
-98	NULL
were	NULL
not	NULL
amenable	NULL
to	NULL
methylation	NULL
interference	NULL
analysis	NULL
,	NULL
because	NULL
only	NULL
small	NULL
amounts	NULL
of	NULL
complex	NULL
were	NULL
formed	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

NF-B	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
TPA-PHA	NULL
treatment	NULL
in	NULL
vivo	NULL
or	NULL
by	NULL
DOC	NULL
treatment	NULL
in	NULL
vitro	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
the	NULL
factor	NULL
that	NULL
is	NULL
activated	NULL
in	NULL
the	NULL
Jurkat	NULL
human	NULL
T-cell	NULL
line	NULL
upon	NULL
treatment	NULL
with	NULL
T-cell-activating	NULL
agents	NULL
would	NULL
bind	NULL
to	NULL
the	NULL
GM-CSF1	NULL
oligonucieotide	NULL
containing	NULL
the	NULL
high-affinity	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
both	NULL
from	NULL
GIBCO	NULL
Laboratories	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
PHA	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
TPA	NULL
(	NULL
both	NULL
from	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
was	NULL
performed	NULL
for	NULL
8	NULL
h.	NULL
A	NULL
corresponding	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

-	NULL
DOC	NULL
+DOC	NULL
§	NULL
TPA+	NULL
TPA	NULL
:	NULL
#	NULL
Treatment	NULL
=	NULL
:	NULL
-	NULL
Co	NULL
-	NULL
PHA	NULL
-	NULL
Co	NULL
ﬂux	NULL
Fraction	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
NC	NULL
pur	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
«	NULL
po_	NULL
_o	NULL
_	NULL
--	NULL
p	NULL
«	NULL
.	NULL

m	NULL
'	NULL
m	NULL
m	NULL
Pe	NULL
a*	NULL
#	NULL
®	NULL
$	NULL
53	NULL
“	NULL
beh	NULL
ba	NULL
b	NULL
fad	NULL
we	NULL
*	NULL
[	NULL
>	NULL
1	NULL
2	NULL
39	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Probe	NULL
GM-CSF	NULL
1	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

T-cell	NULL
activation	NULL
stimulates	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
a	NULL
GM-CSF	NULL
promoter	NULL
element	NULL
.	NULL

For	NULL
EMSAs	NULL
,	NULL
equal	NULL
cell	NULL
equivalents	NULL
of	NULL
fractions	NULL
from	NULL
control	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
and	NULL
from	NULL
induced	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
were	NULL
reacted	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
GM-CSF1	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
prior	NULL
DOC	NULL
treatment	NULL
.	NULL

A	NULL
small	NULL
amount	NULL
of	NULL
pure	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
human	NULL
placenta	NULL
was	NULL
used	NULL
as	NULL
a	NULL
size	NULL
standard	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
.	NULL

Fluorograms	NULL
of	NULL
native	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

Symbols	NULL
:	NULL
»	NULL
,	NULL
NF-	NULL
«	NULL
kB-DNA	NULL
complex	NULL
;	NULL
>	NULL
,	NULL
free	NULL
DNA	NULL
probe	NULL
.	NULL

N	NULL
,	NULL
Nuclear	NULL
fraction	NULL
;	NULL
C	NULL
,	NULL
cytosolic	NULL
fraction	NULL
;	NULL
Co	NULL
,	NULL
control	NULL
.	NULL

amount	NULL
of	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
the	NULL
solvent	NULL
for	NULL
TPA	NULL
,	NULL
was	NULL
added	NULL
to	NULL
control	NULL
cultures	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifu-gation	NULL
and	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
fractions	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
with	NULL
the	NULL
modifications	NULL
described	NULL
previously	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
cytosolic	NULL
fractions	NULL
were	NULL
kept	NULL
frozen	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
subcellular	NULL
fractions	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
equal	NULL
cell	NULL
equivalents	NULL
(	NULL
1.5	NULL
to	NULL
4	NULL
mg	NULL
of	NULL
protein	NULL
per	NULL
m	NULL
!	NULL
)	NULL

were	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

Treatment	NULL
with	NULL
DOC	NULL
(	NULL
E.	NULL
Merck	NULL
AG	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
2.5	NULL
ul	NULL
of	NULL
4	NULL
%	NULL
DOC	NULL
to	NULL
2	NULL
ul	NULL
of	NULL
the	NULL
fractions	NULL
and	NULL
then	NULL
adding	NULL
the	NULL
DNA-binding	NULL
mix	NULL
and	NULL
2	NULL
pl	NULL
of	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Nonidet	NULL
P-40	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
allowed	NULL
for	NULL
30	NULL
min	NULL
and	NULL
were	NULL
analyzed	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Under	NULL
control	NULL
conditions	NULL
,	NULL
the	NULL
GM-CSF1	NULL
probe	NULL
detected	NULL
in	NULL
EMSAs	NULL
several	NULL
DNA-binding	NULL
activities	NULL
in	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
fractions	NULL
,	NULL
among	NULL
them	NULL
a	NULL
very	NULL
weak	NULL
activity	NULL
comigrating	NULL
with	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
purified	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

Upon	NULL
an	NULL
8-h	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
PHA	NULL
and	NULL
TPA	NULL
,	NULL
a	NULL
high	NULL
increase	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
comigrating	NULL
with	NULL
that	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
seen	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
and	NULL
to	NULL
a	NULL
small	NULL
extent	NULL
with	NULL
the	NULL
cytosolic	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
specifically	NULL
inhibited	NULL
by	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
kB	NULL
motif	NULL
of	NULL
the	NULL
mouse	NULL
x	NULL
light-chain	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
further	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
activity	NULL
detected	NULL
by	NULL
the	NULL
GM-CSF1	NULL
probe	NULL
in	NULL
fractions	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
related	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
analyzed	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
fractions	NULL
from	NULL
control	NULL
and	NULL
stimulated	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
Vor	NULL
.	NULL

10	NULL
,	NULL
1990	NULL
DOC	NULL
.	NULL

This	NULL
agent	NULL
was	NULL
shown	NULL
to	NULL
release	NULL
NF-kB	NULL
from	NULL
a	NULL
specific	NULL
cytoplasmic	NULL
inhibitory	NULL
protein	NULL
,	NULL
IxB	NULL
,	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
inactivation	NULL
and	NULL
cytoplasmic	NULL
localization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
uninduced	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
GM-CSF1	NULL
probe	NULL
could	NULL
indeed	NULL
detect	NULL
a	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
was	NULL
activated	NULL
by	NULL
DOC	NULL
in	NULL
cytosolic	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
10	NULL
)	NULL
.	NULL

This	NULL
cytosolic	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
from	NULL
T	NULL
cells	NULL
comigrated	NULL
with	NULL
that	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
purified	NULL
from	NULL
human	NULL
placenta	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
and	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

T-cell	NULL
activation	NULL
led	NULL
to	NULL
a	NULL
reduction	NULL
of	NULL
the	NULL
DOC-dependent	NULL
cytosolic	NULL
activity	NULL
and	NULL
a	NULL
concomitant	NULL
increase	NULL
of	NULL
an	NULL
active	NULL
nuclear	NULL
form	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
with	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

About	NULL
30	NULL
%	NULL
of	NULL
the	NULL
total	NULL
cellular	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
activated	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
compare	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
faster-migrating	NULL
complex	NULL
seen	NULL
under	NULL
control	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
disappeared	NULL
upon	NULL
T-cell	NULL
activation	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
suspect	NULL
that	NULL
a	NULL
constitutive	NULL
factor	NULL
binding	NULL
to	NULL
or	NULL
overlapping	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
like	NULL
KBFI-H2TF1	NULL
)	NULL
became	NULL
displaced	NULL
upon	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
factor	NULL
.	NULL

Our	NULL
observations	NULL
strongly	NULL
suggest	NULL
that	NULL
a	NULL
DNA-binding	NULL
activity	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
NF-KB	NULL
is	NULL
activated	NULL
upon	NULL
stimulation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
by	NULL
PHA	NULL
and	NULL
TPA	NULL
.	NULL

Like	NULL
the	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
human	NULL
placenta	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
the	NULL
GM-CSF	NULL
gene	NULL
and	NULL
is	NULL
thus	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
transcription	NULL
factor	NULL
conferring	NULL
T-cell-activating	NULL
signals	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
all	NULL
available	NULL
criteria	NULL
,	NULL
this	NULL
study	NULL
demonstrates	NULL
that	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
can	NULL
bind	NULL
to	NULL
a	NULL
key	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

(	NULL
i	NULL
)	NULL
In	NULL
EMSAs	NULL
,	NULL
purified	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
strongly	NULL
complex	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
previously	NULL
characterized	NULL
cis-acting	NULL
element	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
unlabeled	NULL
oligonucleotide	NULL
is	NULL
a	NULL
strong	NULL
competitor	NULL
of	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
«	NULL
kB	NULL
motif	NULL
GGGACTTTCC	NULL
,	NULL
comparable	NULL
to	NULL
other	NULL
oligonucleotides	NULL
containing	NULL
well-characterized	NULL
cis-acting	NULL
«	NULL
B	NULL
motifs	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
The	NULL
factor	NULL
that	NULL
is	NULL
activated	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
upon	NULL
TPA-PHA	NULL
treatment	NULL
and	NULL
in	NULL
cytosolic	NULL
fractions	NULL
by	NULL
DOC	NULL
is	NULL
indistinguishable	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
apparently	NULL
recognizes	NULL
the	NULL
«	NULL
kB	NULL
motif	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

The	NULL
idea	NULL
that	NULL
an	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
is	NULL
strongly	NULL
supported	NULL
by	NULL
the	NULL
mutation	NULL
analysis	NULL
data	NULL
from	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

CAT	NULL
constructs	NULL
in	NULL
which	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
at	NULL
positions	NULL
-82	NULL
to	NULL
-91	NULL
was	NULL
abolished	NULL
by	NULL
either	NULL
removing	NULL
sequences	NULL
downstream	NULL
of	NULL
position	NULL
-84	NULL
or	NULL
deleting	NULL
bases	NULL
between	NULL
positions	NULL
-86	NULL
and	NULL
-91	NULL
lost	NULL
their	NULL
inducibility	NULL
upon	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TPA-calcium	NULL
ionophore	NULL
and	NULL
were	NULL
reduced	NULL
significantly	NULL
in	NULL
their	NULL
responses	NULL
to	NULL
transient	NULL
tax	NULL
,	NULL
expression	NULL
.	NULL

Further	NULL
support	NULL
comes	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
segment	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
kB-binding	NULL
site	NULL
could	NULL
confer	NULL
T-cell-activating	NULL
signals	NULL
and	NULL
tax	NULL
,	NULL
expression	NULL
in	NULL
CAT	NULL
assays	NULL
.	NULL

Consistent	NULL
with	NULL
an	NULL
involvement	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
is	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
is	NULL
induced	NULL
upon	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
IL-1	NULL
(	NULL
6	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
21	NULL
)	NULL
;	NULL
both	NULL
cytokines	NULL
were	NULL
recently	NULL
shown	NULL
to	NULL
activate	NULL
NF-KB	NULL
(	NULL
10	NULL
,	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
responsiveness	NULL
of	NULL
the	NULL
CLE	NULL
1	NULL
element	NULL
to	NULL
transient	NULL
expression	NULL
of	NULL
tax	NULL
,	NULL
but	NULL
not	NULL
to	NULL
T-cell-activating	NULL
signals	NULL
(	NULL
20	NULL
)	NULL
might	NULL
also	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
actions	NULL
of	NULL
NF-kB	NULL
.	NULL

As	NULL
suggested	NULL
by	NULL
our	NULL
in	NULL
vitro	NULL
binding	NULL
and	NULL
competition	NULL
data	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
bind	NULL
with	NULL
low	NULL
affinity	NULL
to	NULL
this	NULL
element	NULL
.	NULL

If	NULL
transient	NULL
tax	NULL
,	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
converts	NULL
more	NULL
of	NULL
the	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B	NULL
into	NULL
its	NULL
active	NULL
form	NULL
than	NULL
the	NULL
TPA-calcium	NULL
ionophore	NULL
treatment	NULL
does	NULL
,	NULL
the	NULL
low-affinity	NULL
site	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
would	NULL
preferentially	NULL
respond	NULL
to	NULL
tax	NULL
,	NULL
,	NULL
the	NULL
agent	NULL
gener-	NULL
NOTES	NULL
1285	NULL
ating	NULL
higher	NULL
concentrations	NULL
of	NULL
active	NULL
NF-kB	NULL
.	NULL

Because	NULL
(	NULL
i	NULL
)	NULL
the	NULL
CLE	NULL
1	NULL
motif	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
CK-1	NULL
motif	NULL
)	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
cytokine	NULL
genes	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
had	NULL
only	NULL
a	NULL
weak	NULL
affinity	NULL
for	NULL
this	NULL
element	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
a	NULL
more	NULL
specific	NULL
factor	NULL
with	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
related	NULL
to	NULL
that	NULL
of	NULL
NF-kB	NULL
recognizes	NULL
this	NULL
site	NULL
.	NULL

Such	NULL
a	NULL
factor	NULL
might	NULL
be	NULL
NF-GM	NULL
,	NULL
(	NULL
26	NULL
)	NULL
.	NULL

From	NULL
previous	NULL
studies	NULL
,	NULL
it	NULL
was	NULL
unclear	NULL
whether	NULL
NF-KB	NULL
or	NULL
so-called	NULL
NF-	NULL
«	NULL
B-like	NULL
factors	NULL
are	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
TPA-PHA	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
uncertainty	NULL
came	NULL
from	NULL
the	NULL
observation	NULL
in	NULL
EMSA	NULL
of	NULL
multiple	NULL
complexes	NULL
,	NULL
the	NULL
detection	NULL
of	NULL
several	NULL
protein	NULL
species	NULL
in	NULL
UV-cross-linking	NULL
experiments	NULL
,	NULL
and	NULL
DNA	NULL
affinity	NULL
precipitation	NULL
experiments	NULL
.	NULL

Under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
we	NULL
could	NULL
not	NULL
obtain	NULL
any	NULL
evidence	NULL
that	NULL
the	NULL
factor	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
distinct	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
protein-DNA	NULL
complex	NULL
of	NULL
the	NULL
NF-KB	NULL
induced	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
after	NULL
TPA-PHA	NULL
treatment	NULL
and	NULL
of	NULL
the	NULL
NF-kB	NULL
activated	NULL
in	NULL
vitro	NULL
by	NULL
DOC	NULL
comigrated	NULL
in	NULL
native	NULL
gels	NULL
with	NULL
the	NULL
protein-DNA	NULL
complex	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
purified	NULL
from	NULL
the	NULL
cytosol	NULL
of	NULL
placenta	NULL
and	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
NF-kB	NULL
from	NULL
HeLa	NULL
cytosol	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
two	NULL
50-kDa	NULL
DNA-binding	NULL
protein	NULL
subunits	NULL
and	NULL
two	NULL
65-kDa	NULL
non-DNA-binding	NULL
protein	NULL
subunits	NULL
(	NULL
2a	NULL
)	NULL
.	NULL

A	NULL
50-kDa	NULL
protein	NULL
was	NULL
also	NULL
evident	NULL
from	NULL
protein-DNA	NULL
UV-cross-linking	NULL
experiments	NULL
with	NULL
T-cell	NULL
extracts	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
13	NULL
)	NULL
.	NULL

From	NULL
the	NULL
comigration	NULL
of	NULL
the	NULL
complexes	NULL
in	NULL
native	NULL
gels	NULL
,	NULL
we	NULL
expect	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cells	NULL
has	NULL
the	NULL
same	NULL
protein	NULL
composition	NULL
as	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
placenta	NULL
and	NULL
HeLa	NULL
cells	NULL
and	NULL
is	NULL
therefore	NULL
a	NULL
ubiquituous	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
,	NULL
however	NULL
,	NULL
that	NULL
under	NULL
certain	NULL
assay	NULL
conditions	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
heterotetramer	NULL
is	NULL
associated	NULL
with	NULL
other	NULL
proteins	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
more	NULL
slowly	NULL
migrating	NULL
complexes	NULL
.	NULL

Alternatively	NULL
,	NULL
certain	NULL
kB	NULL
sites	NULL
like	NULL
the	NULL
one	NULL
in	NULL
the	NULL
IL-2R	NULL
promoter	NULL
may	NULL
contain	NULL
flanking	NULL
sequences	NULL
that	NULL
allow	NULL
additional	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
DNA	NULL
probe	NULL
,	NULL
thereby	NULL
creating	NULL
larger	NULL
complexes	NULL
.	NULL

The	NULL
GM-CSF	NULL
gene	NULL
is	NULL
a	NULL
novel	NULL
cytokine	NULL
gene	NULL
whose	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
binding	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

Other	NULL
examples	NULL
are	NULL
the	NULL
genes	NULL
encoding	NULL
IL-2	NULL
(	NULL
13	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
Shakov	NULL
et	NULL
al	NULL
.	NULL

,	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
in	NULL
press	NULL
;	NULL
M.	NULL
Collart	NULL
and	NULL
P.	NULL
Vassalli	NULL
,	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
)	NULL
,	NULL
beta	NULL
interferon	NULL
(	NULL
16	NULL
,	NULL
28	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
T.	NULL
Lieberman	NULL
and	NULL
D.	NULL
Baltimore	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
)	NULL
.	NULL

A	NULL
possible	NULL
candidate	NULL
is	NULL
also	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
B	NULL
gene	NULL
,	NULL
for	NULL
which	NULL
we	NULL
recently	NULL
characterized	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
xB	NULL
in	NULL
the	NULL
upsteam	NULL
promoter	NULL
region	NULL
(	NULL
G.	NULL
Messer	NULL
,	NULL
E.	NULL
Weiss	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

As	NULL
supported	NULL
further	NULL
by	NULL
our	NULL
study	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
serves	NULL
in	NULL
a	NULL
great	NULL
variety	NULL
of	NULL
genes	NULL
within	NULL
upstream	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
can	NULL
rapidly	NULL
induce	NULL
mRNA	NULL
synthesis	NULL
upon	NULL
extra-cellular	NULL
stimulation	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
within	NULL
so-called	NULL
cytokine	NULL
networks	NULL
(	NULL
27	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
key	NULL
role	NULL
in	NULL
signal-ing	NULL
.	NULL

Because	NULL
several	NULL
cytokines	NULL
can	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
because	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
turn	NULL
can	NULL
upregulate	NULL
the	NULL
transcription	NULL
of	NULL
these	NULL
and	NULL
other	NULL
cytokines	NULL
,	NULL
this	NULL
transcription	NULL
factor	NULL
can	NULL
mediate	NULL
positive	NULL
autoregulation	NULL
of	NULL
cytokine	NULL
synthesis	NULL
as	NULL
well	NULL
as	NULL
cross-talking	NULL
between	NULL
distinct	NULL
cytokine	NULL
systems	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Andrea	NULL
Oswald	NULL
for	NULL
synthesizing	NULL
oligonucleo-tides	NULL
,	NULL
Ulrike	NULL
Wagner	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
Margarete	NULL
Beulecke	NULL
for	NULL
help	NULL
with	NULL
typing	NULL
the	NULL
manuscript	NULL
,	NULL
Michael	NULL
Brecht	NULL
for	NULL
help	NULL
with	NULL
preparing	NULL
figures	NULL
,	NULL
and	NULL
E.-L.	NULL
Winnacker	NULL
for	NULL
his	NULL
continuous	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Zentrum	NULL
fiir	NULL
Gentechnologie	NULL
bei	NULL
der	NULL
Universitat	NULL
Miinchen	NULL
,	NULL
e.	NULL
V.	NULL
1286	NULL
2a	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

NOTES	NULL
LITERATURE	NULL
CITED	NULL
.	NULL

Baeverie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217.	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

Bauererle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
by	NULL
1kB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Phorbol-ester-induced	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
involves	NULL
dissociation	NULL
of	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B/inhibitor	NULL
complex	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

53:789-798.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655.	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Sickewitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
protein	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836.	NULL
.	NULL

Broudy	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
J.	NULL
M.	NULL
Harlan	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Adamson	NULL
.	NULL

1987	NULL
.	NULL

Interleukin	NULL
1	NULL
stimulates	NULL
human	NULL
endothelial	NULL
cells	NULL
to	NULL
produce	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139	NULL
:	NULL
464-468.	NULL
.	NULL

Chan	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
D.	NULL
J.	NULL
Slamon	NULL
,	NULL
S.	NULL
D.	NULL
Nimer	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
human	NULL
granulocyte/	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:8669-8673.	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-kB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
k	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244	NULL
:	NULL
466-469.	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Duh	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
W.	NULL
J.	NULL
Maury	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
activates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
through	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NF-kB	NULL
sites	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5974-5978	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-278	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
339:70-73	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Kappa	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:457-460	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

Identi-	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

fication	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4700-4704	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.-M	NULL
.	NULL

Fan	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
xB-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331-2335	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
R.	NULL
DeWaal	NULL
,	NULL
T.	NULL
Heike	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
Y.	NULL
Takebe	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
cell	NULL
derived	NULL
lymphokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
fibroblasts	NULL
:	NULL
effects	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
p40*	NULL
protein	NULL
and	NULL
bovine	NULL
papilloma	NULL
virus	NULL
encoded	NULL
E2	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:6547-6566	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

T-cell	NULL
activation	NULL
signals	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40*	NULL
protein	NULL
activate	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
through	NULL
a	NULL
common	NULL
DNA	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:5581-5587	NULL
.	NULL

Munker	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Gasson	NULL
,	NULL
M.	NULL
Ogawa	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1986	NULL
.	NULL

Recombinant	NULL
human	NULL
TNF	NULL
induces	NULL
production	NULL
of	NULL
granulocyte-monocyte	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:79-82	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711~713	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
E.	NULL
A.	NULL
Morita	NULL
,	NULL
M.	NULL
J.	NULL
Martis	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
region	NULL
by	NULL
genetic	NULL
analysis	NULL
:	NULL
correlation	NULL
with	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1979-1984	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

1989	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1988	NULL
.	NULL

Nuclear	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
granulo-cyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

1988	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:674-678	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
1988	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6:439-464	NULL
.	NULL

Visvanathan	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1989	NULL
.	NULL

Double-stranded	NULL
RNA	NULL
activates	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
an	NULL
inducible	NULL
element	NULL
in	NULL
the	NULL
human	NULL
B-interferon	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1129-1138	NULL
.	NULL

